The NOBEL SYMPOSIA mark is owned by the Nobel Foundation
Nobel Symposium 175 was funded by the Royal Swedish Academy of Sciences and organized by Richard Rosenquist Brandell, MD, PhD, Professor of Clinical Genetics, Karolinska Institutet, Sweden.
This symposium will focus on precision medicine in rare diseases, cancer, infectious diseases, and complex diseases and address a broad range of key aspects including development of new technologies, informatics solutions, diagnostic approaches and targeted therapies, based on discoveries in basic research. The symposium will also encompass precision medicine beyond genomics as well as international perspectives on precision medicine.
The following experts are confirmed as speakers: Aarno Palotie, Albrecht Stenzinger, Ahmet Zehir, Anna Lindstrand, Anna Wedell, Annika Östman Wernerson, Berend Snijder, Bettina Ryll, Christian Gilissen, Eleftheria Zeggini, Elli Papaemmanouil, Eric Duncavage, Fabrice André, Jakob Forssmed, Jane Davies, Jerry Mendell, Jordi Merino, Judith Breuer, Kjetil Tasken, Laurence De Leval, Melanie Börries, Naomi Wray, Olli Kallioniemi, Paul Franks, Per Falk, Peter Johansen, Razelle Kurzrock, Sascha Dietrich, Sten Eirik Jacobsen, Sue Hill, Ulrik Lassen.